Patents by Inventor Lien LÓPEZ MATILLA

Lien LÓPEZ MATILLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INORGANIC NANOPARTICLE-BASED VACCINE COMPOSITIONS FOR CANCER TREATMENT
    Publication number: 20230226163
    Abstract: The present invention is related to biotechnology, particularly to the field of human health. It provides new vaccine compositions that comprise as active principle a system that contains the recombinant human EGF, or peptides thereof, and a carrier protein or peptide, bound to a nucleus constituted by inorganic nanoparticles, with nanometric or submicrometric scale dimensions. These vaccine compositions are useful for the chronic treatment of cancer and have as advantages that their administration does not result in the appearance of adverse effects at the injection site and that they do not accumulate in the body.
    Type: Application
    Filed: May 31, 2021
    Publication date: July 20, 2023
    Inventors: Gustavo González Ruiz, David Alejandro González Martínez, Fernando Bordallo León, Belinda Sánchez Ramírez, Kalet León Monzón, Yerandy Echeverría Luna, Maria del Carmen Luzardo Lorenzo, Mabel Cruz Rodríguez, Adys González Palomo, Julio Felipe Santo Tomás Pompa, Judey Aymed García Artalejo, Elaine Ruiz Castro, Lien López Matilla
  • USE OF THE BASIC FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF A PATIENTS WITH SPINOCEREBELLAR ATAXIA WITH CAG REPEAT MUTATIONS
    Publication number: 20210060127
    Abstract: The present invention relates to use of pharmaceutical compositions that have as active ingredient the basic form of recombinant human erythropoietin (rhEPO) and that are administered nasally for the treatment of spinocerebellar ataxia (SCA) with mutations of CAG repeats type, particularly of SCA type 2. Another object of the present invention is a method for stratifying patients into responders and non-responders to treatment with the basic form of rhEPO.
    Type: Application
    Filed: June 8, 2017
    Publication date: March 4, 2021
    Inventors: Daniel Enrique AMARO GONZÁLEZ, Luis Clodoaldo VELÁZQUEZ PÉREZ, Julio César GARCÍA RODRÍGUEZ, Roberto RODRÍGUEZ LABRADA, lliana María SOSA TESTÉ, Ricardo ORTEGA SÁNCHEZ, Patricia HERNÁNDEZ CASAÑA, Consuelo GONZÂLEZ TRIANA, Daniel JAY PÉREZ, Lien LÓPEZ MATILLA, Daise JIMÉNEZ RODRÍGUEZ